According to the terms of the deal, healthcare providers using Mellitus Health’s Insulin Insights titration service will have access to real-time patient data from Smart Meter’s iGlucose Cellular Diabetes Care solution. Combining these offerings will help healthcare teams better manage patients’ insulin therapy regimens, according to the companies.
“We’re excited to combine the remote monitoring power of iGlucose’s easy-to-use solution with our software’s precision insulin dosing recommendations to bring better glycemic control to insulin-using people with diabetes,” Josh Davidson, CEO of Mellitus Health, said in prepared remarks. “A recent remote monitoring study using our Insulin Insights software showed a 2.4% drop in HbA1c in only 180 days, with no change in patient lifestyle and no severe hypoglycemic events. We hope to help many more patients achieve similar life-changing outcomes through our collaboration with iGlucose.”
“Obtaining reliable, timely data to properly dose and adjust insulin has always been a challenge for providers and their patients. Our partnership with Mellitus Health will undoubtedly alleviate hurdles, improve insulin titration recommendations and ultimately deliver better outcomes,” Cliff McIntosh, CEO of Smart Meter, added. “We are extremely proud of the role our iGlucose solution will play in improving diabetes management.”